141 related articles for article (PubMed ID: 3618534)
1. Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.
Francis RM; Peacock M
Am J Clin Nutr; 1987 Aug; 46(2):315-8. PubMed ID: 3618534
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
3. Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups.
Zerwekh JE; Sakhaee K; Glass K; Pak CY
J Clin Endocrinol Metab; 1983 Feb; 56(2):410-3. PubMed ID: 6600460
[TBL] [Abstract][Full Text] [Related]
4. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel.
Francis RM; Peacock M; Taylor GA; Storer JH; Nordin BE
Clin Sci (Lond); 1984 Jan; 66(1):103-7. PubMed ID: 6606522
[TBL] [Abstract][Full Text] [Related]
5. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
Lawoyin S; Zerwekh JE; Glass K; Pak CY
J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and molecular mechanism of action of vitamin D: 1981.
DeLuca HF
Biochem Soc Trans; 1982 Jun; 10(3):147-58. PubMed ID: 7049788
[TBL] [Abstract][Full Text] [Related]
7. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
Riggs BL; Nelson KI
J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
Need AG; Horowitz M; Philcox JC; Nordin BE
Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
[TBL] [Abstract][Full Text] [Related]
9. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study 1,25-dihydroxycholecalciferols and 24,25-dihydroxycholecalciferols effect on ionized calcium level in blood plasma of patients with osteoporosis].
Khodyrev VN; Spirichev VB
Vopr Pitan; 2005; 74(2):15-9. PubMed ID: 15921199
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
Caniggia A; Vattimo A
Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
[TBL] [Abstract][Full Text] [Related]
12. [The effects of oral doses of 1, 25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 on intestinal calcium absorption and serum 1, 25-dihydroxyvitamin D level: a study in healthy adults and in postmenopausal osteoporosis].
Shigeno C; Morita R; Fukunaga M; Yamamoto I; Dokoh S; Hino M; Yamada K; Furumatsu C; Endo K; Mukai T; Iida Y; Torizuka K
Nihon Naibunpi Gakkai Zasshi; 1982 Dec; 58(12):1473-81. PubMed ID: 6897777
[No Abstract] [Full Text] [Related]
13. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.
Brown SA; Ontjes DA; Lester GE; Lark RK; Hensler MB; Blackwood AD; Caminiti MJ; Backlund DC; Aris RM
Osteoporos Int; 2003 Jun; 14(5):442-9. PubMed ID: 12774194
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol.
Reeve J; Tellez M; Green JR; Hesp R; Elsasser U; Wootton R; Hulme P; Williams D; Kanis JA; Russell RG; Mawer EB; Meunier PJ
Acta Endocrinol (Copenh); 1982 Dec; 101(4):636-40. PubMed ID: 6984270
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.
Sakhaee K; Nicar MJ; Glass K; Zerwekh JE; Pak CY
J Clin Endocrinol Metab; 1984 Dec; 59(6):1037-43. PubMed ID: 6490791
[TBL] [Abstract][Full Text] [Related]
18. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-mediated calcium absorption in patients with clinically stable Crohn's disease: a pilot study.
Kumari M; Khazai NB; Ziegler TR; Nanes MS; Abrams SA; Tangpricha V
Mol Nutr Food Res; 2010 Aug; 54(8):1085-91. PubMed ID: 20306476
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic use of vitamin D, its derivatives and their analogs].
Vagneur JP; Argemi B
Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
